| Primary |
| Drug Use For Unknown Indication |
42.8% |
| Product Used For Unknown Indication |
23.8% |
| Sinusitis |
5.4% |
| Ear Infection |
4.2% |
| Pyrexia |
4.1% |
| Bronchitis |
2.7% |
| Upper Respiratory Tract Infection |
2.1% |
| Cystitis |
1.8% |
| Infection |
1.8% |
| Drug Exposure During Pregnancy |
1.6% |
| Pharyngitis Streptococcal |
1.4% |
| Streptococcal Infection |
1.1% |
| Upper Respiratory Tract Inflammation |
1.1% |
| Laryngeal Injury |
1.0% |
| Pyelonephritis Acute |
1.0% |
| Tonsillitis |
0.9% |
| Otitis Media |
0.8% |
| Pharyngitis |
0.8% |
| Urinary Tract Infection |
0.8% |
| Acute Tonsillitis |
0.7% |
|
| Faeces Discoloured |
17.2% |
| Urticaria |
14.1% |
| Vomiting |
10.4% |
| Rash |
7.3% |
| Diarrhoea |
5.7% |
| Stevens-johnson Syndrome |
5.2% |
| Clostridial Infection |
4.7% |
| Hepatic Function Abnormal |
4.2% |
| Haematochezia |
3.6% |
| Liver Disorder |
3.6% |
| Pain |
3.1% |
| Serum Sickness |
3.1% |
| Crying |
2.6% |
| Toxic Skin Eruption |
2.6% |
| Accidental Overdose |
2.1% |
| Anaphylactic Reaction |
2.1% |
| Blood Glucose Increased |
2.1% |
| Hypersensitivity |
2.1% |
| Interstitial Lung Disease |
2.1% |
| Overdose |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
34.3% |
| Product Used For Unknown Indication |
17.8% |
| Ill-defined Disorder |
10.5% |
| Pyrexia |
9.3% |
| Upper Respiratory Tract Inflammation |
2.8% |
| Hypertension |
2.6% |
| Sinusitis |
2.5% |
| Cough |
2.1% |
| Cystitis |
2.1% |
| Upper Respiratory Tract Infection |
1.9% |
| Bronchitis |
1.6% |
| Infection |
1.6% |
| Nasopharyngitis |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Enterocolitis |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Tonsillitis |
1.4% |
| Inflammatory Bowel Disease |
1.2% |
| Tooth Extraction |
1.2% |
| Erythema Multiforme |
1.1% |
|
| Stevens-johnson Syndrome |
8.5% |
| Vomiting |
7.0% |
| Completed Suicide |
5.6% |
| Portal Vein Phlebitis |
5.6% |
| Portal Vein Thrombosis |
5.6% |
| Pseudomembranous Colitis |
5.6% |
| Pyrexia |
5.6% |
| Renal Impairment |
5.6% |
| Rheumatoid Arthritis |
5.6% |
| Vanishing Bile Duct Syndrome |
5.6% |
| Viral Rash |
5.6% |
| Colitis Ulcerative |
4.2% |
| Interstitial Lung Disease |
4.2% |
| Respiratory Arrest |
4.2% |
| Shock |
4.2% |
| Urticaria |
4.2% |
| Uveitis |
4.2% |
| Alanine Aminotransferase Increased |
2.8% |
| Clostridium Difficile Infection |
2.8% |
| Dehydration |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.2% |
| Drug Use For Unknown Indication |
15.0% |
| Prophylaxis |
8.9% |
| Pain |
6.7% |
| Hypertension |
5.7% |
| Constipation |
4.6% |
| Infection Prophylaxis |
4.2% |
| Contraception |
3.9% |
| Asthma |
3.5% |
| Rheumatoid Arthritis |
3.3% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Atrial Fibrillation |
3.1% |
| Juvenile Arthritis |
3.0% |
| Pyrexia |
2.7% |
| Nasopharyngitis |
2.6% |
| Acute Myocardial Infarction |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Diabetes Mellitus |
2.4% |
| Nausea |
2.4% |
| Acne |
2.4% |
|
| Weight Decreased |
12.2% |
| White Blood Cell Count Decreased |
10.3% |
| Pyrexia |
8.5% |
| Pulmonary Embolism |
7.5% |
| Deep Vein Thrombosis |
6.6% |
| Pneumonia |
6.6% |
| Vomiting |
6.6% |
| Cardiac Failure |
3.8% |
| Dyspnoea |
3.8% |
| Pain In Extremity |
3.8% |
| Renal Disorder |
3.8% |
| Wheezing |
3.8% |
| Gallbladder Disorder |
3.3% |
| Nausea |
3.3% |
| Pain |
2.8% |
| Pancreatitis Acute |
2.8% |
| Subarachnoid Haemorrhage |
2.8% |
| Thrombocytopenia |
2.8% |
| Visual Field Defect |
2.8% |
| Arthralgia |
2.3% |
|
